Hyperion Capital Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
Other funds holding GMED
JT
SC
Hyperion Capital Advisors's GMED Position: Q2 2026 in Review
Hyperion Capital Advisors reduced its Globus Medical (GMED) stake by 49% in Q2 2026, selling an estimated $5.9M and leaving 71,476 shares worth $5.65M. The position accounts for 2.55% of the portfolio, ranked #12.
Hyperion Capital Advisors first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $12.8M in Q4 2025. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.
- Hyperion Capital Advisors held 71,476 shares of Globus Medical worth $5.65M as of Q2 2026.
- Hyperion Capital Advisors sold 69,373 Globus Medical shares in Q2 2026, an estimated $5.9M.
- Globus Medical made up 2.55% of Hyperion Capital Advisors's portfolio in Q2 2026, its #12 holding.
- Hyperion Capital Advisors first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
- Hyperion Capital Advisors's Globus Medical position peaked at $12.8M in Q4 2025.
- 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.
Based on Hyperion Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.